ABCA1-dependent but apoA-I-independent cholesterol efflux mediated by fatty acid-bile acid conjugates (FABACs)

The Biochemical Journal
Ilana GoldinerAlbert K Groen

Abstract

FABACs (fatty acid-bile acid conjugates) are synthetic molecules that are designed to treat a range of lipid disorders. The compounds prevent cholesterol gallstone formation and diet-induced fatty liver, and increase reverse cholesterol transport in rodents. The aim of the present study was to investigate the effect of FABACs on cholesterol efflux in human cells. Aramchol (3beta-arachidylamido-7alpha,12alpha,5beta-cholan-24-oic acid) increased cholesterol efflux from human skin fibroblasts in a dose-dependent manner in the absence of known efflux mediators such as apoA-I (apolipoprotein A-I), but had little effect on phospholipid efflux. An LXR (liver X receptor) agonist strongly increased Aramchol-induced cholesterol efflux; however, in ABCA1 (ATP-binding cassette transporter A1)-deficient cells from Tangier disease patients, the Aramchol effect was absent, indicating that activity of ABCA1 was required. Aramchol did not affect ABCA1 expression, but plasma membrane levels of the transporter increased 2-fold. Aramchol is the first small molecule that induces ABCA1-dependent cholesterol efflux without affecting transcriptional control. These findings may explain the beneficial effect of the compound on atherosclerosis.

References

Jun 30, 1988·Biochemical and Biophysical Research Communications·T TsujinakaT Mori
Mar 1, 1989·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·N A Mazer
Oct 1, 1985·Analytical Biochemistry·P K SmithD C Klenk
Oct 14, 2000·Annual Review of Cell and Developmental Biology·J J Repa, D J Mangelsdorf
Sep 11, 2001·Biochemical and Biophysical Research Communications·M J van WijlandA K Groen
Mar 1, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tuvia GilatFred M Konikoff
Mar 16, 2002·Laboratory Investigation; a Journal of Technical Methods and Pathology·Cheryl L WellingtonMichael R Hayden
Apr 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·Robert J AielloOmar L Francone
Apr 25, 2002·Proceedings of the National Academy of Sciences of the United States of America·Miranda van EckGerd Schmitz
Nov 30, 2002·Trends in Cardiovascular Medicine·Didier Marguet, Giovanna Chimini
Jan 18, 2003·Biochimica Et Biophysica Acta·Yannick HamonGiovanna Chimini
Mar 5, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·John F Oram
Apr 5, 2003·Drug News & Perspectives·John F. Oram
Apr 8, 2003·Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology·A GonenD Harats
Apr 18, 2003·Journal of Lipid Research·Ashley M Vaughan, John F Oram
Apr 18, 2003·Journal of Lipid Research·G Kees HovinghAlbert K Groen
May 10, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Nan Wang, Alan R Tall
Jul 4, 2003·European Journal of Gastroenterology & Hepatology·Fred M KonikoffTuvia Gilat
Jul 19, 2003·The Journal of Biological Chemistry·Laurent O MartinezAlan R Tall
Jul 29, 2003·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Tuvia GilatFred M Konikoff
Sep 6, 2003·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Ilana GoldinerWillem Kulik
Aug 1, 1959·Canadian Journal of Biochemistry and Physiology·E G BLIGH, W J DYER
Jan 1, 2004·The Journal of Biological Chemistry·Bassam HaidarJacques Genest
Jan 30, 2004·Biochemical Society Transactions·A Leikin-FrenkelF M Konikoff
Sep 24, 2004·The Journal of Biological Chemistry·Charulatha VedhachalamMichael C Phillips
Nov 3, 2004·Journal of Lipid Research·Maki TsujitaShinji Yokoyama
Mar 31, 2005·The Journal of Biological Chemistry·Hui ZhengYves L Marcel
May 14, 2005·Current Opinion in Lipidology·Shinji Yokoyama
May 21, 2005·The Journal of Biological Chemistry·Nele Alder-BaerensAndreas Herrmann
Jun 1, 2005·Biochimica Et Biophysica Acta·Gerd Schmitz, Thomas Langmann

❮ Previous
Next ❯

Citations

Mar 25, 2016·Annals of Indian Academy of Neurology·Madhu NagappaSanjib Sinha
Nov 4, 2010·Archives of Medical Research·Alicia Leikin-FrenkelTuvia Gilat
Jul 27, 2010·Trends in Cardiovascular Medicine·Martin H KangMichael R Hayden
Mar 24, 2016·Digestive Diseases and Sciences·Vlad Ratziu
May 13, 2014·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Rifaat SafadiUNKNOWN FLORA Group
Nov 8, 2008·European Journal of Gastroenterology & Hepatology·Alicia Leikin-FrenkelTuvia Gilat
May 1, 2021·International Journal of Molecular Sciences·Hyunmi KimKyoung-Jin Oh
Jul 28, 2021·Advanced Drug Delivery Reviews·Virender KumarRam I Mahato
Jan 3, 2008·Archives of Biochemistry and Biophysics·Alicia Leikin-FrenkelTuvia Gilat

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Archives of Biochemistry and Biophysics
Alicia Leikin-FrenkelTuvia Gilat
European Journal of Gastroenterology & Hepatology
Alicia Leikin-FrenkelTuvia Gilat
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Tuvia GilatFred M Konikoff
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Ilana GoldinerWillem Kulik
© 2021 Meta ULC. All rights reserved